Market Pulse

Columna built it, Migros bought it

Three Ardentis clinic companies in Yverdon, Vevey and Lausanne absorbed the legacy Clinident entities on contracts dated 29 June 2026, published in the gazette on 15 July, a month before Columna Capital's sale of the group to Medbase was announced on 18 August 2026.

Ronal AG of Härkingen absorbed its wholly owned research and toolmaking subsidiary Ron AG on a merger contract dated 6 August 2026, taking on CHF 21.1 million of assets and CHF 12.0 million of third-party liabilities. Ron AG was struck from the register on 18 August.

Gravis Robotics AG of Zurich, an ETH Zurich spin-off, announced a USD 200 million Series A led by SoftBank Investment Advisers on 17 August 2026. No valuation was disclosed.

7Press-Reported Dealsup from 4 WoW
564Distress Events+46% WoW
2Startup FundingCHF 172.0M converted
11Succession Signalsup from 2 WoW
891New Registrations-1% WoW
2181Board Changes+12% WoW

Columna Capital closed the sale of its majority stake in Ardentis on Friday 14 August and announced it the following Tuesday. Twenty dental clinics across French-speaking Switzerland, about 450 staff, roughly 70,000 patients a year. The London firm came in at the end of 2019; management reinvested for a minority, and co-CEOs Mark Bischof and Yves Corthésy stayed. No price was published, and none can be derived from what is.

The buyer is the half worth thinking about. Medbase is Migros — roughly 190 medical centres, practices, pharmacies and dental centres attached to the country's largest retailer. Swiss regulated-services platforms are increasingly built by a fund and bought by a domestic strategic with a customer base, rather than passed from one fund to the next. Medbase carries sixteen arms-length acquisitions on our books before this one, the first in 2017, and it is not finished. If you own a platform in a regulated Swiss service, that is who to call.

Underneath the deals, the supply is growing. 8,898 Swiss companies had a bankruptcy notice published between 1 January and 29 August, against 6,092 last year and 4,441 in 2024, on total register traffic up only 11 per cent. Zurich, Geneva, Ticino and Bern all rose. This week's 356 notices are inflated by the courts coming back from the summer recess, which happens every August — but the annual line does not bend back.

Elsewhere: Holcim agreed to buy Fermacell from James Hardie for EUR 840 million, and Gravis Robotics, an ETH Zurich spin-off, took USD 200 million from SoftBank for software that turns an excavator into an autonomous machine. Twenty registry M&A filings against ten the week before, 891 new companies, 2,181 board changes, 564 distress events.

The Valais dealer that moved its business and kept the building

CODE41 SA has been in a composition moratorium since February and nobody has written about it.

The Lausanne watch brand — mechanical watches sold direct to buyers online rather than through retailers — was granted a sursis concordataire définitif by the president of the Lausanne district court on 19 February 2026. Six months, running to 28 August. Peter Kladny was appointed commissioner. Nothing has been published since, it is absent from the press feed we track, and a search turns up no coverage at all.

The register shows how it got there. Converting from Sàrl to SA in 2022 forced CODE41 to publish a balance sheet: CHF 5.66 million of assets against CHF 5.43 million of third-party liabilities, leaving CHF 222,823 of net assets. In 2023 it created 288,568 participation certificates, the instrument its community of small holders owns. In October 2025 it exercised a conditional capital increase, conversion rights turning into 11.45 million shares. Four months later the court granted the moratorium.

That deadline has now passed. Whatever was filed on 28 August — a composition agreement, an extension, or bankruptcy — decides who ends up owning one of the better-known names in independent Swiss watchmaking.

The Signals

Unlock the signals — free

Pre-deal signals scored before the press, federal procurement prints, the complete deal tape, the forward court calendar and buyable estates. Free, every Friday.

Free weekly newsletter. Unsubscribe anytime.

Based on 5,410 SOGC/SHAB publications processed this week. M&A data sourced from Swiss commercial registry filings (20 SOGC), press-reported transactions via web intelligence (7 EXA), and startup funding from Startupticker, Tech.eu, and company disclosures (2 rounds). Company distress scoring based on proprietary multi-signal model across 113,000 Swiss companies. Valuation benchmarks supplemented from Deloitte Swiss M&A reports and Dealsuite DACH data. Restatement. This edition and 2026-W35 were rebuilt after a fault in our extraction pipeline silently dropped registry deal and distress extraction between 21 August and 1 September 2026; the window from 17 August to 1 September was re-extracted on 1 September on a new model and a rewritten prompt. Two consequences for anyone comparing against earlier figures. Board-change counts for 17-20 August are lower than the original run produced, because the earlier prompt read the German register marker "[bisher: …]" as a new arrival rather than as a change to an existing appointment, and roughly twenty of those phantom events remain in the 17-20 August window pending cleanup. Distress counts for the same window are higher, because the earlier prompt missed plainly worded "Konkurs eröffnet" notices. Separately, and as stated in every edition since 10 August 2026, our bankruptcy count excludes notices that revoke a bankruptcy, so these figures are not comparable with editions published before that date.

ValIndex reads every SOGC filing the day it publishes, scores 113,000 Swiss companies for distress and succession, and shows the workings. Weekly. Request access →